orphan drug designation
Scope
Date
~
-
Bio & Pharma
Zuellig mulls acquiring S.Korea’s top drug distributor Geo-Young
Asia’s leading drug distributor Zuellig Pharma is considering the acquisition of Geo-Young Corp., the largest medicine wholesaler in South Kor...
Oct 18, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HD Hyundai, Siemens to jointly build smart shipyard
South Korean HD Hyundai Co. and Siemens, a Germany-based global smart engineering company, will jointly develop a data platform for building a smart...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Red ginseng proven to treat drug addiction: Research
It has been revealed that red ginseng significantly improves drug addiction and withdrawal symptoms caused by substance abuse. The research results ...
Oct 17, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB gets global rights to Chinese liver cancer drug
South Korea’s HLB Therapeutics Co. on Tuesday said its US subsidiary Elevar Therapeutics has acquired the global rights excluding South Kore...
Oct 17, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
Cosmax forms dedicated suncare OTC team
Cosmax Inc., South Korea's largest cosmetics manufacturer that specializes in original design manufacturing (ODM), announced on Thursday the establi...
Oct 12, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
KT, Hyundai Livart to pursue DX in home interior
South Korea’s KT Corp. and furniture and interior company Hyundai Livart Furniture are pursuing Premium Interior Digital Transformation (DX), ...
Oct 12, 2023 (Gmt+09:00)
-
Electronics
LG Electronics unveils new gaming monitor tailored for LoL
LG Electronics Inc. 's new LG UltraGear gaming monitor is optimized for both performance and design and customized for the world-famous multiplayer ...
Oct 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Proxy adviser ISS backs drug giant Celltrion's merger plan
South Korean drug giant Celltrion Group has received a positive recommendation from Institutional Shareholder Services (ISS), a global leading proxy...
Oct 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Ildong Pharma to spin off R&D subsidiary in Nov
South Korea’s Ildong Pharmaceutical Co. will spin off its research and development (R&D) unit into the subsidiary Yunovia from Nov. 1.&nbs...
Oct 06, 2023 (Gmt+09:00)
-
Petrochemicals
Samsung Eng. wins $19.5 mn Saudi petrochemical plant design contract
South Korea's Samsung Engineering has secured a front end engineering design (FEED) project for a PDH·PP·UTOS Plant in Saudi Arabia, m...
Sep 27, 2023 (Gmt+09:00)
-
Automobiles
Genesis unveils redesigned GV80, first-ever GV80 Coupe
Hyundai Motor Co.'s premium brand Genesis on Wednesday unveiled the partially redesigned model of its flagship sports utility vehicle (SUV), the GV8...
Sep 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewon Pharma to export $3 mn worth of Pelubi to Indonesia
South Korea's Daewon Pharmaceutical Co. will export its nonsteroidal anti-inflammatory drug (NSAID) Pelubi to the Indonesian market. It's South Kore...
Sep 25, 2023 (Gmt+09:00)
-
Artificial intelligence
Rebellions teams up with IBM for ATOM AI chip quality test
Rebellions Inc., a South Korean artificial intelligence chip design startup, said on Monday it has forged a partnership with US tech giant IBM to co...
Sep 25, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
SK Chemicals to sell pharmaceutical unit to Glenwood PE
SK Chemicals Co., a South Korean plastic materials producer, is in exclusive talks with Seoul-based Glenwood Private Equity to sell its pharmaceutic...
Sep 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
SK becomes top shareholder of US contract drug maker CBM
SK Pharmteco Co., a South Korean contract development and manufacturing organization (CDMO), said on Wednesday it has secured management rights of t...
Sep 20, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
SW based on Hancom's tech released in Taiwan
South Korea's office suite software maker Hancom Inc. on Monday said it has released Kdan Office, the Taiwanese office software co-developed with gl...
Sep 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong to develop eye drops for diabetic retinopathy
South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...
Sep 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Science joins race to develop Wegovy competitor
Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio to sell dementia drug AR1001 in China with partner
South Korea's clinical-stage biotech company AriBio Co. on Wednesday said it signed a memorandum of understanding on strategic cooperation with Chin...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Wellmarker Bio signs worth of $528 mn tech transfer deal
Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...
Sep 12, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong gets patent of Nabota as migraine drug in US
South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it has received a patent from the US Patent and Trademark Office for the use of...
Sep 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Yungjin Pharm's new drug candidate gets Fast Track from FDA
South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...
Sep 06, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Boryung gets gov’t OK for diabetes drug Trubuddy
South Korea’s Boryung Corp. on Tuesday said it received approval from the Ministry of Food and Drug Safety for its new compound diabetes drug ...
Sep 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand new plant for drug products
South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday that it plans to enlarge its finished pharmaceuticals manufacturing facility...
Sep 05, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N releases K-Cab in Singapore
South Korean bio-health company HK inno.N announced on Monday that it has released the new drug K-CAB for gastroesophageal reflux disease (GERD) in ...
Sep 04, 2023 (Gmt+09:00)
-
Fashion
Korea emerges as growth market, design hub for global brands
Global fashion and luxury goods brands are opening directly managed stores in South Korea, one of their growth markets, ending their decades-long re...
Sep 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Discovery in S.Korea promises dieting without limits on eating
A drug candidate in South Korea could allow people seeking to lose weight to eat to their heart's content.The Center for Cognition and Sociality of ...
Sep 01, 2023 (Gmt+09:00)
Latest News
- 1 Maybe Happy Ending: How a Seoul-made robot love story rewrote the Broadway playbook
- 2 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 3 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 4 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 5 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs